Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M
Med Oncol. 2025; 42(4):108.
PMID: 40087196
DOI: 10.1007/s12032-025-02675-8.
Wang S, Chen Y, Huang S, Fu Y, Lin S, Jiang S
Oncogenesis. 2025; 14(1):6.
PMID: 40069143
PMC: 11897235.
DOI: 10.1038/s41389-025-00549-2.
Liao T, Chen X, Qiu F, Zhang X, Wu F, Zhao Z
J Nanobiotechnology. 2025; 23(1):166.
PMID: 40038745
PMC: 11877876.
DOI: 10.1186/s12951-025-03217-0.
Almehizia A, Naglah A, Aljafen S, Hassan A, Aboulthana W
Pharmaceutics. 2025; 17(2).
PMID: 40006547
PMC: 11859031.
DOI: 10.3390/pharmaceutics17020180.
Yin C, Liufu C, Ye S, Zhu T, Jiang J, Wang M
Cell Mol Biol Lett. 2025; 30(1):20.
PMID: 39956902
PMC: 11830183.
DOI: 10.1186/s11658-025-00687-w.
pH of Microenvironment Directly Modulates the Phenotype and Function of Cancer-Associated Fibroblasts.
Li Y, He C, Shen A, Wang Y, Xu Z, Zhang L
ACS Omega. 2025; 10(4):3937-3943.
PMID: 39926491
PMC: 11799978.
DOI: 10.1021/acsomega.4c09716.
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method.
Feng Q, Shan X, Yau V, Cai Z, Xie S
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861125
PMC: 11769033.
DOI: 10.3390/ph18010062.
TGF-β signaling orchestrates cancer-associated fibroblasts in the tumor microenvironment of human hepatocellular carcinoma: unveiling insights and clinical significance.
Ge J, Jiang H, Chen J, Chen X, Zhang Y, Shi L
BMC Cancer. 2025; 25(1):113.
PMID: 39838288
PMC: 11753146.
DOI: 10.1186/s12885-025-13435-2.
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy.
Zhang Z, Wang R, Chen L
Int J Nanomedicine. 2025; 20():483-503.
PMID: 39816375
PMC: 11734509.
DOI: 10.2147/IJN.S500591.
The molar dose of FAPI administered impacts on the FAP-targeted PET imaging and therapy in mouse syngeneic tumor models.
Liu L, Shi Y, He S, Yang J, Song S, Wang D
Eur J Nucl Med Mol Imaging. 2025; .
PMID: 39797968
DOI: 10.1007/s00259-025-07071-y.
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects.
Cao Z, Quazi S, Arora S, Osellame L, Burvenich I, Janes P
J Biomed Sci. 2025; 32(1):7.
PMID: 39780187
PMC: 11715488.
DOI: 10.1186/s12929-024-01099-2.
From ductal carcinoma in situ to invasive breast cancer: the prognostic value of the extracellular microenvironment.
Hulahan T, Angel P
J Exp Clin Cancer Res. 2024; 43(1):329.
PMID: 39716322
PMC: 11664872.
DOI: 10.1186/s13046-024-03236-z.
Pan-cancer analysis combined with experimental validation revealed that is an immunological and prognostic biomarker.
Ouyang Y, Shen Y, Lai S, Huang H, Huang Y, Ren S
Transl Cancer Res. 2024; 13(11):5830-5844.
PMID: 39697730
PMC: 11651810.
DOI: 10.21037/tcr-24-752.
myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment.
Fang H, Dai W, Gu R, Zhang Y, Li J, Luo W
J Hematol Oncol. 2024; 17(1):126.
PMID: 39696364
PMC: 11657131.
DOI: 10.1186/s13045-024-01643-5.
Recent Advances of Small Extracellular Vesicles for the Regulation and Function of Cancer-Associated Fibroblasts.
Liang C, Wang M, Huang Y, Yam J, Zhang X, Zhang X
Int J Mol Sci. 2024; 25(23).
PMID: 39684264
PMC: 11641781.
DOI: 10.3390/ijms252312548.
Extracellular nicotinamide phosphoribosyltransferase visfatin activates JAK2-STAT3 pathway in cancer-associated fibroblasts to promote colorectal cancer metastasis.
Lei Y, Shu D, Xia J, Zhang T, Wei H
Genes Genomics. 2024; .
PMID: 39643827
DOI: 10.1007/s13258-024-01596-6.
Fibroblast Activation Protein-α Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregulation to Adverse....
Qin Y, Miyake T, Muramoto K, Maekawa T, Nishina Y, Wang Y
Ann Surg Oncol. 2024; 32(3):1941-1952.
PMID: 39623187
DOI: 10.1245/s10434-024-16593-y.
Personalized nanovaccines for treating solid cancer metastases.
Feng T, Hu J, Wen J, Qian Z, Che G, Zhou Q
J Hematol Oncol. 2024; 17(1):115.
PMID: 39609851
PMC: 11603676.
DOI: 10.1186/s13045-024-01628-4.
Biomaterials' enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment.
Santerre J, Yang Y, Du Z, Wang W, Zhang X
Front Immunol. 2024; 15:1492323.
PMID: 39600709
PMC: 11588700.
DOI: 10.3389/fimmu.2024.1492323.
Research Progress of Fibroblasts in Human Diseases.
Li X, Li N, Wang Y, Han Q, Sun B
Biomolecules. 2024; 14(11).
PMID: 39595654
PMC: 11591654.
DOI: 10.3390/biom14111478.